Importance of entero-salivary recirculation in paracetamol pharmacokinetics

Biopharmaceutics and Drug Disposition

Volumn 23, Issue 6, 2002, Pages 245-249

  Schaiquevich, Paula ^a   Niselman, Ada ^b   Rubio, Modesto ^a  

^a Instituto de Investigaciones Farmacológias ININFA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Entero salivary circulation; Paracetamol; Salivary secretion

Indexed keywords

PARACETAMOL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HYDROLYSIS; DRUG SALIVA LEVEL; FEMALE; GASTROINTESTINAL TRACT; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SALIVATION; SAMPLE; STATISTICAL ANALYSIS; SWALLOWING; TABLET FORMULATION; VOLUNTEER;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEGLUTITION; FEMALE; HUMANS; INTESTINAL ABSORPTION; MALE; SALIVA; TIME FACTORS;

EID: 0036739509     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.316     Document Type: Article

References (20)

1. Smith M, Withehead E, O'Sullivan G, Reynolds F. A comparison of serum and saliva paracetamol concentrations. Br J Clin Pharmac 1991; 31: 553-555.
2. Fagiolino P, Vázquez M. Bioequivalence study of paracetamol in saliva. Eur J Drug Metab Pharmacokinet 1994; Special issue:164-168.
3. Posti J. Saliva-plasma drug concentration ratios durng absorption: Theoretical considerations and pharmacokinetic implications. Pharm Acta Helv 1982; 57(3): 83-92.
4. Adithan C, Thangam J. A comparative study of saliva and serum paracetamol levels using a simple spectrophotometric method. Br J Clin Pharmac 1982; 14:107-109.
5. Cardot JM, et al. Bioavailability study of paracetamol by means of salivary samples. J Pharm Clin 1986; 5(3): 241-256.
6. Glynn J, Bastain W. Salivary excretion of paracetamol in man. J Pharm Pharmacol 1973; 25: 420-421.
7. Kamali F, Fry J, Bell G. Salivary secretion of paracetamol in man. J Pharm Pharmacol 1987; 39: 150-152.
8. Kamali F, Edwards C, Rawlins M. The effect of pirenzepine on gastric emptying and salivary flow rate: Constraints on the use of saliva paracetamol concentrations for the determination of paracetamol pharmacokinetics. Br J Clin Pharmacol 1992; 33: 309-312.
9. Vázquez M, Fagiolino F, De Nucci G, Parrillo S, Piñeyro A. Post-prandial reabsorption of paracetamol. Eur J Drug Metab Pharmacokinet 1993; Special issue: 177-183.
10. Fagiolino P. Implicancias farmacocinéticas y biofarmacéuticas de las concentraciones salivales de fármaco. In Monitorización de fármacos en saliva: aplicaciones biofarmacéuticas, farmacocinéticas y terapéticas, Fagiolino P (ed). Comisión Sectorial de Investigación Cientifica de la Universidad de la República, Uruguay, 1999; 39-62.
11. Siegers C, Loeser W, Gieselmann J, Oltmanns D. Biliary and renal excretion of paracetamol in man. Pharmacology 1984; 29: 301-303.
12. Siegers C, Rozman K, Klaassen C. Biliary excretion and enterohepatic circulation of paracetamol in the rat. Xenobiotica 1983; 13(10): 591-596.
13. Clements J, Heading R, Nimmo S, Prescott L. Kinetics of the acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther 1978; 24 (4): 420-431.
14. Headding R, Nimmo S, Prescott L, Tothill P. The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol 1973; 47: 415-421.
15. Oberle R, Amidon G. The influence of variable gastric emptying and intestinal rates on the plasma level curve of cimetidine. An explanation for double peak phenomenon. J Pharmacokinet Biopharmcol 1987; 15(5): 529-544.
16. Goicoechea A, López de Alda M, Vila-Jato J. A validated high-performance liquid chromatographic method for the determination of paracetamol and its major metabolites in urine. J Liquid Chromatogr 1995; 18(16): 3257-3268.
17. Goicoechea A, Vila-Jato J. Acetaminophen presystemic biotransformation vs bioavailability in therapeutical dosage range. Eur J Drug Metab Pharmacokinet 1998 Apr-Jun; 23(2): 333-338.
18. Forrest J, Clements J, Prescott L. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982; 7: 93-107.
19. Ritschel W, Kearns G. Handbook of Basic Pharmacokinetics including Clinical Applications. American Pharmaceutical Association: Washington, DC, 1999.
20. Heinzel G, Woloscczak R, Thomann P. Pharmacokinetic and Pharmacodynamic Data Analysis System. TOPFIT 2.0. Gustav Fischer Verlag/VCH Publishers: New York, 1993.